- Home
- MLCO vs LMAT Comparison
MLCO vs LMAT Comparison
Compare MLCO & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLCO
- LMAT
- Stock Information
- Founded
- MLCO 2004
- LMAT 1983
- Country
- MLCO Hong Kong
- LMAT United States
- Employees
- MLCO N/A
- LMAT N/A
- Industry
- MLCO Hotels/Resorts
- LMAT Medical/Dental Instruments
- Sector
- MLCO Consumer Discretionary
- LMAT Health Care
- Exchange
- MLCO Nasdaq
- LMAT Nasdaq
- Market Cap
- MLCO 2.6B
- LMAT 1.9B
- IPO Year
- MLCO 2006
- LMAT 2006
- Fundamental
- Price
- MLCO $6.28
- LMAT $82.20
- Analyst Decision
- MLCO Hold
- LMAT Buy
- Analyst Count
- MLCO 5
- LMAT 7
- Target Price
- MLCO $7.06
- LMAT $100.67
- AVG Volume (30 Days)
- MLCO 3.0M
- LMAT 225.6K
- Earning Date
- MLCO 05-08-2025
- LMAT 05-01-2025
- Dividend Yield
- MLCO N/A
- LMAT 0.97%
- EPS Growth
- MLCO N/A
- LMAT 30.45
- EPS
- MLCO 0.14
- LMAT 1.97
- Revenue
- MLCO $4,758,114,000.00
- LMAT $226,256,000.00
- Revenue This Year
- MLCO $8.77
- LMAT $13.58
- Revenue Next Year
- MLCO $2.87
- LMAT $8.81
- P/E Ratio
- MLCO $44.08
- LMAT $41.74
- Revenue Growth
- MLCO 14.07
- LMAT 13.19
- 52 Week Low
- MLCO $4.55
- LMAT $71.42
- 52 Week High
- MLCO $8.90
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- MLCO 62.52
- LMAT 47.25
- Support Level
- MLCO $6.03
- LMAT $80.54
- Resistance Level
- MLCO $6.54
- LMAT $83.67
- Average True Range (ATR)
- MLCO 0.19
- LMAT 2.29
- MACD
- MLCO -0.01
- LMAT -0.07
- Stochastic Oscillator
- MLCO 49.02
- LMAT 48.61
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts and Entertainment Ltd is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao with the rest largely from the Philippines as of 2024.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.